Parkinson's & Movement disorders

Parkinson's vaccine – clinical results boost prospects

AFFiRiS AG announced today results of AFF008A, a Phase I clinical trial to assess boost immunizations with AFFITOPE PD01A, an active vaccine against Parkinson's disease (PD). The study was funded by a $1.04 million grant ...

Parkinson's & Movement disorders

Blocking key enzyme halts Parkinson's disease symptoms in mice

Researchers at Johns Hopkins say they have gleaned two important new clues in the fight against Parkinson's disease: that blocking an enzyme called c-Abl prevents the disease in specially bred mice, and that a chemical tag ...

Parkinson's & Movement disorders

Identifying a genetic mutation behind sporadic Parkinson's disease

Using a novel method, Whitehead Institute researchers have determined how a non-coding mutation identified in genome-wide association studies (GWAS) can contribute to sporadic Parkinson's disease (PD). The approach could ...

Parkinson's & Movement disorders

Cell-free circulating mtDNA identifies Parkinson's disease

(HealthDay)—Cell-free circulating mitochondrial DNA (ccf-mtDNA) from cerebrospinal fluid (CSF) is reduced in patients with Parkinson's disease (PD), according to research published in the December issue of the Annals of ...

page 4 from 23